Ovarian Cancer Trial, Recruiting NCT06852313 Sponsor: University Children's Hospital, Zurich Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06852313
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and young people aged 12 months to 18 years with an ovarian cyst that is 4 cm or larger and is causing symptoms, where surgery has been recommended.
  • Children and young people aged 12 months to 18 years with an ovarian cyst that is 4 cm or larger that has no symptoms, but surgery has been recommended because the cyst has stayed the same size or grown over time.
  • Children and young people aged 12 months to 18 years with an ovarian cyst that is 4 cm or larger that has no symptoms, but surgery is planned for another related reason that was known about before the operation.
  • Cases where both ovaries have a qualifying cyst — each ovary would be counted separately in the trial.
  • Parents or legal guardians, and the patient themselves where appropriate, have given consent to participate; for patients who are not able to give consent due to their health or development, there should be no signs that they are unwilling to take part.

Who may not be able to join:

  • Babies under 12 months of age with an ovarian cyst.
  • People older than 18 years.
  • People with a more complex cyst that contains solid parts (for example, a teratoma), or where there is any concern or suspicion of cancer.
  • People with cysts located near but not on the ovary (known as paratubal or paraovarian cysts).
  • People who have a medical condition that would make cyst removal surgery unsafe (for example, a serious blood clotting disorder).
  • Cases where a signed consent form has not been provided, or where the parent, guardian, or patient does not have sufficient ability in German, French, or English to give informed consent.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0041 2494949

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Children's Hospital, Zurich
Registry
ClinicalTrials.gov
Start date
5 February 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Postoperative change of AMH level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov